Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Maxime Boussageon, Aurélie Swalduz & Maurice Pérol. (2021) The safety and efficacy of erlotinib and ramucirumab combination in EGFR-mutant non-small-cell lung cancer. Expert Review of Anticancer Therapy 21:10, pages 1071-1080.
Read now
Read now
Yan Hu, Siying Ren, Yu He, Li Wang, Chen Chen, Jingqun Tang, Wenliang Liu & Fenglei Yu. (2020) Possible Oncogenic Viruses Associated with Lung Cancer. OncoTargets and Therapy 13, pages 10651-10666.
Read now
Read now
Lu-Lu Huang, Mei Tang, Qian-Qian Du, Chun-Xia Liu, Chen Yan, Jin-Ling Yang & Yan Li. (2019) The effects and mechanisms of a biosynthetic ginsenoside 3β,12β-Di-O-Glc-PPD on non-small cell lung cancer. OncoTargets and Therapy 12, pages 7375-7385.
Read now
Read now
Dimitra Grapsa, Konstantinos Syrigos & Muhammad Wasif Saif. (2015) Bevacizumab in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy for first-line and maintenance treatment of metastatic colorectal cancer. Expert Review of Anticancer Therapy 15:11, pages 1267-1281.
Read now
Read now
Virginie Hervé, Nathalie Rabbe, Laurent Guilleminault, Flora Paul, Laurène Schlick, Nicolas Azzopardi, Michael Duruisseaux, Delphine Fouquenet, Jérôme Montharu, Françoise Redini, Gilles Paintaud, Etienne Lemarié, Jacques Cadranel, Marie Wislez & Nathalie Heuzé-Vourc’h. (2014) VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations. mAbs 6:6, pages 1638-1648.
Read now
Read now
Articles from other publishers (52)
Taisuke Araki, Shintaro Kanda, Hidehito Horinouchi & Yuichiro Ohe. (2023)
Current treatment strategies for
EGFR
-mutated non-small cell lung cancer: from first line to beyond osimertinib resistance
. Japanese Journal of Clinical Oncology 53:7, pages 547-561.
Crossref
Crossref
Zhen-Ling Liu, Huan-Huan Chen, Li-Li Zheng, Li-Ping Sun & Lei Shi. (2023) Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Suman Kumar Ray & Sukhes Mukherjee. (2023) Interaction Among Noncoding RNAs, DNA Damage Reactions, and
Genomic Instability in the Hypoxic Tumor: Is it Therapeutically
Exploitable Practice?. Current Molecular Medicine 23:3, pages 200-215.
Crossref
Crossref
Charnay Cunningham, Julie Bolcaen, Alessandra Bisio, Amanda Genis, Hans Strijdom & Charlot Vandevoorde. (2023) Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer. Pharmaceuticals 16:2, pages 219.
Crossref
Crossref
Feng Wang, Shengnan Wei, Zexuan Zhang, Yuan Zhang, Jingya He & Bin Sun. (2022) Osimertinib: Another medication related to osteonecrosis of the jaws? A case report and literature review. Frontiers in Pharmacology 13.
Crossref
Crossref
Aaron C. Tan & Nick Pavlakis. (2022) Anti-Angiogenic Therapy in ALK Rearranged Non-Small Cell Lung Cancer (NSCLC). International Journal of Molecular Sciences 23:16, pages 8863.
Crossref
Crossref
Chike Osude, Leo Lin, Meet Patel, Adam Eckburg, Joseph Berei, Adijan Kuckovic, Namrata Dube, Aayush Rastogi, Shruti Gautam, Thomas J. Smith, Shylendra B. Sreenivassappa & Neelu Puri. (2022) Mediating EGFR-TKI Resistance by VEGF/VEGFR Autocrine Pathway in Non-Small Cell Lung Cancer. Cells 11:10, pages 1694.
Crossref
Crossref
Chiara Lazzari, Alessandra Bulotta, Giuseppe Damiano, Aurora Mirabile, Mariagrazia Viganó, Giulia Veronesi & Vanesa Gregorc. (2022) Angiogenesis inhibition in lung cancer: emerging novel strategies. Current Opinion in Oncology 34:1, pages 107-114.
Crossref
Crossref
Shu-Ling HsiehJia-Huei LiCheng-Di DongChiu-Wen ChenChih-Chung Wu. (2021) Carnosine suppresses human colorectal cancer cell proliferation by inducing necroptosis and autophagy and reducing angiogenesis. Oncology Letters 23:2.
Crossref
Crossref
Margarita Neganova, Junqi Liu, Yulia Aleksandrova, Sergey Klochkov & Ruitai Fan. (2021) Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment. Cancers 13:23, pages 6062.
Crossref
Crossref
Rui Hu, Qi Wang, Yanfei Jia, Yingchun Zhang, Bin Wu, Shan Tian, Yujie Wang, Yunshan Wang & Wanshan Ma. (2021) Hypoxia-induced DEC1 mediates trophoblast cell proliferation and migration via HIF1α signaling pathway. Tissue and Cell 73, pages 101616.
Crossref
Crossref
Meng Qiao, Tao Jiang, Xinyu Liu, Shiqi Mao, Fei Zhou, Xuefei Li, Chao Zhao, Xiaoxia Chen, Chunxia Su, Shengxiang Ren & Caicun Zhou. (2021) Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn?. Journal of Thoracic Oncology 16:8, pages 1267-1288.
Crossref
Crossref
Jeong Cha, Woom-Yee Bae, Jae-Sun Choi, Seung Lee & Joo-Won Jeong. (2021) Angiogenic activities are increased via upregulation of HIF‑1α expression in gefitinib‑resistant non‑small cell lung carcinoma cells. Oncology Letters 22:3.
Crossref
Crossref
Julien Ancel, Jeanne-Marie Perotin, Maxime Dewolf, Claire Launois, Pauline Mulette, Béatrice Nawrocki-Raby, Véronique Dalstein, Christine Gilles, Gaëtan Deslée, Myriam Polette & Valérian Dormoy. (2021) Hypoxia in Lung Cancer Management: A Translational Approach. Cancers 13:14, pages 3421.
Crossref
Crossref
Xiuning Le, Monique Nilsson, Jonathan Goldman, Martin Reck, Kazuhiko Nakagawa, Terafumi Kato, Luis Paz Ares, Bente Frimodt-Moller, Katharina Wolff, Carla Visseren-Grul, John V. Heymach & Edward B. Garon. (2021) Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC. Journal of Thoracic Oncology 16:2, pages 205-215.
Crossref
Crossref
Iwona Ziółkowska-Suchanek. (2021) Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models. Cells 10:1, pages 141.
Crossref
Crossref
Tse-Chun Kuo, Hsing-Jien Kung & Jing-Wen Shih. (2020) Signaling in and out: long-noncoding RNAs in tumor hypoxia. Journal of Biomedical Science 27:1.
Crossref
Crossref
Foteinos-Ioannis D. Dimitrakopoulos, Anastasia E. Kottorou, Melpomeni Kalofonou & Haralabos P. Kalofonos. (2020) The Fire Within: NF-κB Involvement in Non–Small Cell Lung Cancer. Cancer Research 80:19, pages 4025-4036.
Crossref
Crossref
Stephanie N. Shishido, Anders Carlsson, Jorge Nieva, Kelly Bethel, James B. Hicks, Lyudmila Bazhenova & Peter Kuhn. (2019) Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer. Journal of Translational Medicine 17:1.
Crossref
Crossref
Chenguang Zhang, Jianke Li, Mengyue Sun, Shujing Li, Jingyu Li, Quanhai Li & Zhenlong Zhu. (2019) Peripheral vessel and air bronchograms for detecting the pathologic patterns of subsolid nodules. Clinical Imaging 56, pages 63-68.
Crossref
Crossref
Stacy K. Y. FanBrian LiQingyang ChenMehran Midia. (2018) Impact of Interventional Oncology Therapies on Tumor Microenvironment and Strategies to Enhance Their Efficacy. American Journal of Roentgenology 210:3, pages 648-656.
Crossref
Crossref
Jing-Wen Shih & Hsing-Jien Kung. (2017) Long non-coding RNA and tumor hypoxia: new players ushered toward an old arena. Journal of Biomedical Science 24:1.
Crossref
Crossref
Mary Jo Fidler, Casey Frankenberger, Richard Seto, Gabriela C. Lobato, Cristina L. Fhied, Selina Sayidine, Sanjib Basu, Mark Pool, Reem Karmali, Marta Batus, Wen-Rong Lie, David Hayes, Jehangir Mistry, Philip Bonomi & Jeffrey A. Borgia. (2017) Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy. Oncotarget 8:35, pages 58108-58121.
Crossref
Crossref
Jian-Shuang Shao, Jian Sun, Shiyu Wang, Katherine Chung, Jin Tong Du, Jason Wang, Xue-Shan Qiu, En-Hua Wang & Guang-Ping Wu. (2017) HPV16 E6/E7 upregulates HIF-2α and VEGF by inhibiting LKB1 in lung cancer cells. Tumor Biology 39:7, pages 101042831771713.
Crossref
Crossref
Shinsaku Togo, Yukiko Namba & Kazuhisa Takahashi. 2017. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease
333
352
.
Ching-Wen Lin, Lu-Kai Wang, Shu-Ping Wang, Yih-Leong Chang, Yi-Ying Wu, Hsuan-Yu Chen, Tzu-Hung Hsiao, Wei-Yun Lai, Hsuan-Hsuan Lu, Ya-Hsuan Chang, Shuenn-Chen Yang, Ming-Wei Lin, Chi-Yuan Chen, Tse-Ming Hong & Pan-Chyr Yang. (2016) Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis. Nature Communications 7:1.
Crossref
Crossref
Xuli Yang, Li Wang, Wenli Sai, Yin Cai, Juanjuan Gu, Xin Chen & Dengfu Yao. (2016) Clinicopathological features of hypoxia-inducible factor-1α and vascular endothelial growth factor expression in patients with lung cancer ⁎. Oncology and Translational Medicine 2:6, pages 261-267.
Crossref
Crossref
Dong Xue, Ye Yang, Yawei Liu, Peiwen Wang, Yi Dai, Qinqiang Liu, Lijun Chen, Jian Shen, Huanyu Ju, Yuan Li & Zhenguo Tan. (2016) MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signaling. Oncotarget 7:48, pages 79805-79813.
Crossref
Crossref
Giuseppe Bronte, Francesco Passiglia, Antonio Galvano, Nadia Barraco, Angela Listì, Marta Castiglia, Sergio Rizzo, Eugenio Fiorentino, Viviana Bazan & Antonio Russo. (2016) Nintedanib in NSCLC: evidence to date and place in therapy. Therapeutic Advances in Medical Oncology 8:3, pages 188-197.
Crossref
Crossref
Chunxia Zhou, Lincai Ye, Chuan Jiang, Jie Bai, Yongbin Chi & Haibo Zhang. (2015) Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer. Tumor Biology 36:12, pages 9179-9188.
Crossref
Crossref
Yunkou Wu, Guiyang Hao, Saleh Ramezani, Debabrata Saha, Dawen Zhao, Xiankai Sun & A. Dean Sherry. (2015)
[
68
Ga]-HP-DO3A-nitroimidazole: a promising agent for PET detection of tumor hypoxia
. Contrast Media & Molecular Imaging 10:6, pages 465-472.
Crossref
Crossref
Hong Shen, Ganzhu Feng, Jin Cui, Qiang Du, Yong Qin, Jiankang Cai, Li Shen & Yina Zhu. (2015) Clinical Implications of Serum Hypoxia Inducible Factor-1α and Vascular Endothelial Growth Factor in Lung Cancer. Tumori Journal 101:4, pages 404-411.
Crossref
Crossref
JINGLI SHI, FEI LIU, WENZHANG ZHANG, XIN LIU, BIHUA LIN & XUDONG TANG. (2015) Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells. Oncology Reports 33:6, pages 2972-2980.
Crossref
Crossref
Kenneth O'Byrne. (2015) Stimulating immune responses to fight cancer: Basic biology and mechanisms. Asia-Pacific Journal of Clinical Oncology 11, pages 9-15.
Crossref
Crossref
Odd Terje Brustugun. (2015) Hypoxia as a Cause of Treatment Failure in Non–Small Cell Carcinoma of the Lung. Seminars in Radiation Oncology 25:2, pages 87-92.
Crossref
Crossref
Takeshi Nakajima, Norihiko Takeda, Tomoyo Taguchi & Mitsuyoshi Azuma. (2015) Design, Synthesis, and Biological Activity Evaluation of Thiazolidinones Containing Alkynyl and Alkenyl Furans for Disrupting Protein–Protein Interactions between HIF-1α and p300. HETEROCYCLES 91:2, pages 351.
Crossref
Crossref
Xiao-han Shen, Peng Qi & Xiang Du. (2015) Long non-coding RNAs in cancer invasion and metastasis. Modern Pathology 28:1, pages 4-13.
Crossref
Crossref
Tina El Rayes, Raul Catena, Shahin Rafii, Nasser Altorki & Vivek Mittal. 2015. Inflammation and Lung Cancer. Inflammation and Lung Cancer
137
159
.
Lupeng Li, Lixiang Wang, Ping Song, Xue Geng, Xiuming Liang, Minran Zhou, Yangyang Wang, Chunyan Chen, Jihui Jia & Jiping Zeng. (2014) Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis. Molecular Cancer 13:1.
Crossref
Crossref
Erying Zhang, Xiaowei Feng, Fei Liu, Peihua Zhang, Jie Liang & Xudong Tang. (2014) Roles of PI3K/Akt and c-Jun Signaling Pathways in Human Papillomavirus Type 16 Oncoprotein-Induced HIF-1α, VEGF, and IL-8 Expression and In Vitro Angiogenesis in Non-Small Cell Lung Cancer Cells. PLoS ONE 9:7, pages e103440.
Crossref
Crossref
Hong Jian, Bin Liu & Jie Zhang. (2014) Hypoxia and hypoxia-inducible factor 1 repress SEMA4B expression to promote non-small cell lung cancer invasion. Tumor Biology 35:5, pages 4949-4955.
Crossref
Crossref
Chien-Hung Huang, Peter Mu-Hsin Chang, Yong-Jie Lin, Cheng-Hsu Wang, Chi-Ying F. Huang & Ka-Lok Ng. (2014) Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer. BioMed Research International 2014, pages 1-13.
Crossref
Crossref
ZHAO Ren-Ping, LIN Sen-Sen, Sheng-Tao YUAN, Bo-Yang YU, Xian-Shu BAI, Li SUN & Lu-Yong ZHANG. (2014) DT-13, a saponin of dwarf lilyturf tuber, exhibits anti-cancer activity by down-regulating C-C chemokine receptor type 5 and vascular endothelial growth factor in MDA-MB-435 cells. Chinese Journal of Natural Medicines 12:1, pages 24-29.
Crossref
Crossref
Jun Liang, Ying Qian, Dan Xu, Qun Yin & Hui-Juan Pan. (2013) Serum Tumor Markers, Hypoxia-Inducible factor-1α HIF-1α and Vascular Endothelial Growth Factor, in Patients with Non-small Cell Lung Cancer Before and after Intervention. Asian Pacific Journal of Cancer Prevention 14:6, pages 3851-3854.
Crossref
Crossref
Cong Li, Hua-Jun Lu, Fei-Fei Na, Lei Deng, Jian-Xin Xue, Jing-Wen Wang, Yu-Qing Wang, Qiao-Ling Li & You Lu. (2013) Prognostic Role of Hypoxic Inducible Factor Expression in Non-small Cell Lung Cancer: A Meta-analysis. Asian Pacific Journal of Cancer Prevention 14:6, pages 3607-3612.
Crossref
Crossref
Fu Yang, Xi-song Huo, Sheng-xian Yuan, Ling Zhang, Wei-ping Zhou, Fang Wang & Shu-han Sun. (2013) Repression of the Long Noncoding RNA-LET by Histone Deacetylase 3 Contributes to Hypoxia-Mediated Metastasis. Molecular Cell 49:6, pages 1083-1096.
Crossref
Crossref
Li He, Erying Zhang, Jingli Shi, Xiangyong Li, Keyuan Zhou, Qunzhou Zhang, Anh D. Le & Xudong Tang. (2013) (−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α. Cancer Chemotherapy and Pharmacology 71:3, pages 713-725.
Crossref
Crossref
Peter I. Kalmar, Peter Schedlbauer, Martin Wehrschütz, Otto C. Dörfler, Hannes A. Deutschmann, Freyja-Maria Smolle-Jüttner & Rupert H. Portugaller. (2013) The efficacy of empiric arterial embolization for treating severe hemoptysis. Open Journal of Internal Medicine 03:02, pages 37-41.
Crossref
Crossref
Vijaya Karoor, Mysan Le, Daniel Merrick, Karen A. Fagan, Edward C. Dempsey & York E. Miller. (2012) Alveolar Hypoxia Promotes Murine Lung Tumor Growth through a VEGFR-2/EGFR-Dependent Mechanism. Cancer Prevention Research 5:8, pages 1061-1071.
Crossref
Crossref
Gang Li, Li He, Erying Zhang, Jingli Shi, Qunzhou Zhang, Anh D. Le, Keyuan Zhou & Xudong Tang. (2011) Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1α and VEGF expression in non-small cell lung cancer cells. Cancer Letters 311:2, pages 160-170.
Crossref
Crossref
Yong Li, Zhi Guo, Yan-ping Han & Xiu-ying Guo. (2011) Expressions of MVD, VEGF, Ki67 in residual prostate cancer after cryoablation. Clinical Oncology and Cancer Research 8:1, pages 27-32.
Crossref
Crossref
Jiani Zheng, Zhiqiao Liu, Gang Chen, Yuanyuan Zhao, Yunpeng Yang, Wenfeng Fang & Li Zhang. (2022) Impact of Smoking Status on the Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors Plus Anti-Vascular Endothelial Growth Factor Antibodies in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. SSRN Electronic Journal.
Crossref
Crossref